The Vascular Dementias and Cerebrovascular Involvement in Alzheimer’s Disease

  • J. G. Schulz
  • K. M. Einhäupl
Conference paper
Part of the Ernst Schering Research Foundation Workshop book series (SCHERING FOUND, volume 17)


The blood stream is a trade route between the brain and the rest of the body. It provides various nutrients and clears waste products, receives and delivers signals, may be blocked or disrupted, and exposes the brain to harmful and unknown external agents. How disturbed vascular trafficking in the brain may end in a syndrome that presents clinically as dementia may be categorized in the following way:
  1. 1.

    Global cerebral ischemia due to cardiogenic dysfunction (watershed infarcts)

  2. 2.

    Focal cerebral ischemia due to vascular occlusion (multi-infarct dementia, MID; strategic infarct)

  3. 3.

    Chronic hypoperfusion due to functional changes of the cerebral microvasculature (Binswanger’s disease, Alzheimer’ s disease, AD?)

  4. 4.

    Cerebral hemorrhage due to focal weakness of the cerebrovasculature (intracerebral hemorrhage, amyloid angiopathy)

In acute ischemic processes with complete infarction the clinical picture directly depends upon how large a lesion is and where it is located, because the brain tissue involved is simply lost for further use. This occurs instantaneously and can be detected by neuroimaging. In contrast, whether and how chronic ischemic processes or incomplete infarction may affect the brain may depend upon further unknown variables. They are not necessarily detected by neuroimaging and do not coincide with onset of clinical symptoms. As a consequence, it is difficult to attribute slowly progressing dementia to underlying vascular causes. Therefore such causes may be underestimated and remain to be elucidated.


Down Syndrome Vascular Dementia Cerebral Amyloid Angiopathy White Matter Change Amyloid Beta Protein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abe K, Tanzi RE, Kogure K (1991) Selective induction of Kunitz-type protease inhibitor domain-containing amyloid precursor protein mRNA after persistent focal ischemia in rat cerebral cortex. Neurosci Lett 125 (2): 172–174PubMedCrossRefGoogle Scholar
  2. Allsop D, Ikeda S, Bruce M, Glenner GG (1988) Cerebrovascular amyloid in scrapie-affected sheep reacts with antibodies to prion protein. Neurosci Lett 92: 234–239PubMedCrossRefGoogle Scholar
  3. Alzheimer’s Disease Collaborative Group (1993) Apolipoprotein E genotype and Alzheimer’s disease. Lancet 342: 737–738Google Scholar
  4. Amouyel P, Vidal O, Launay JM, Laplanche JL (1994) The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. The French Research Group on Epidemiology of Human Spongiform Encephalopathies. Lancet 344: 1315–1318Google Scholar
  5. An G, Lin TN, Liu JS, Xue JJ, He YY, Hsu CY (1993) Expression of c-fos and c-jun family genes after focal cerebral ischemia. Ann Neurol 33: 457464Google Scholar
  6. Aronow BJ, Lund SD, Brown TL, Harmony JA, Witte DP (1993) Apolipoprotein J expression at fluid-tissue interfaces: potential role in barrier cytoprotection. Proc Natl Acad Sci USA 90: 725–729Google Scholar
  7. Aronson MK, Ooi WL, Morgenstern H, Hafner A, Masur D, Crystal H, Fisher D, Katzman R (1990) Women, myocardial infarction, and dementia in the very old. Neurology 40: 1102–1106PubMedCrossRefGoogle Scholar
  8. Banati RB, Gehrmann J, Wiessner C, Hossmann KA, Kreutzberg GW (1995) Glial expression of the beta-amyloid precursor protein ( APP) in global ischemia. J Cereb Blood Flow Metab 15: 647–654Google Scholar
  9. Blöndal H, Guomundsson G, Benedikz E, Johannesson G (1989) Dementia in hereditary cystatin C amyloidosis. Prog Clin Biol Res 317: 157–164PubMedGoogle Scholar
  10. Bowen BC, Barker WW, Loewenstein DA, Sheldon J, Duara R (1990) MR signal abnormalities in memory disorder and dementia. AJR Am J Roentgeno1154: 1285–1292Google Scholar
  11. Bowes MP, Masliah E, Otero DA, Zivin JA, Saitoh T (1994) Reduction of neurological damage by a peptide segment of the amyloidbeta/A4 protein precursor in a rabbit spinal cord ischemia model. Exp Neurol 129: 112–119PubMedCrossRefGoogle Scholar
  12. Boyles JK, Pitas RE, Wilson E, Mahley RW, Taylor JM (1985) Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest 76 (4): 1501–1513Google Scholar
  13. Boyles JK, Zoellner CD, Anderson LJ, Kosik LM, Pitas RE, Weisgraber KH, Mahley RW, Gebicke Haerter PJ, Ignatius MJ, Shooter EM (1989) A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Invest 83: 1015–1031PubMedCrossRefGoogle Scholar
  14. Boyles JK, Notterpek LM, Anderson LJ (1990) Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. Identification of apolipoprotein D, apolipoprotein-IV, apolipoprotein E, and apolipoprotein A-I. J Biol Chem 265 (29): 17805–17815PubMedGoogle Scholar
  15. Brun A, Englund E (1986) A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol 19: 253–262PubMedCrossRefGoogle Scholar
  16. Busciglio J, Gabuzda DH, Matsudaira P, Yankner BA (1993) Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells. Proc Natl Acad Sci USA 90: 2092–2096PubMedCrossRefGoogle Scholar
  17. Bush AI, Martins RN, Rumble B, Moir R, Fuller S, Milward E, Currie J, Weidemann A, Fischer P, Multhaup G, Beyreuther K, Masters CL (1990) The amyloid precursor protein of Alzheimer’s disease is released by human platelets. J Biol Chem 265: 15977–15983PubMedGoogle Scholar
  18. Buxbaum JD, Koo EH, Greengard P (1993) Protein phosphorylation inhibits production of Alzheimer amyloid beta/A4peptide. Proc Natl Acad Sci USA 90: 9195–9198PubMedCrossRefGoogle Scholar
  19. Carlsson J, Armstrong VW, Reiber H, Felgenhauer K, Seidel D (1991) Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid. Clin Chim Acta 196: 167–176Google Scholar
  20. Chen M, Inestrosa NC, Ross GS, Fernandez HL (1995) Platelets are the primary source of amyloid beta-peptide in human blood. Biochem Biophys Res Commun 213 (1): 96–103PubMedCrossRefGoogle Scholar
  21. Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, Lieberburg I, Selkoe DJ (1992) Mutation of the beta-amyloid precursor protein in familial Alzheimer’s disease increases beta-protein production. Nature 360: 672–674PubMedCrossRefGoogle Scholar
  22. Clark AW, Krekoski CA, Parhad IM, Liston D, Julien JP, Hoar DI (1989) Altered expression of genes for amyloid and cytoskeletal proteins in Alzheimer cortex. Ann Neurol 25: 331–339PubMedCrossRefGoogle Scholar
  23. Coffman JA, Torello MW, Bornstein RA, Chakeres D, Burns E, Nasrallah HA (1990) Leukoaraiosis in asymptomatic adult offspring of individuals with Alzheimer’s disease. Biol Psychiatry 27: 1244–1248PubMedCrossRefGoogle Scholar
  24. Cole T, Dickson PW, Esnard F, Averill S, Risbridger GP, Gauthier F (1989) The cDNA structure and expression analysis of the genes for the cysteine proteinase inhibitor cystatin C and for beta 2-microglobulin in rat brain. Eur J Biochem 186: 35–42PubMedCrossRefGoogle Scholar
  25. Davies L, Wolska B, Hilbich C, Multhaup G, Martins R, Simms G, Beyreuther K, Masters Cl (1988) A4 amyloid protein deposition and the diagnosis of Alzheimer’s disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques. Neuro-logy 38 (11): 1688–1693Google Scholar
  26. Davignon J, Gregg RE, Sing CF (1988) Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8: 1–21Google Scholar
  27. Dragunow M, Goulding M, Fau11 RL, Ralph R, Mee E, Frith R (1990) Induc-tion of c-fos mRNA and protein in neurons and glia after traumatic brain injury: pharmacological characterization. Exp Neurol 107: 236–248PubMedCrossRefGoogle Scholar
  28. Duara R (1994) Neuroimaging with CT and MRI in Alzheimer Disease. In: Terry RD, Katzman R, Bick KL (eds) Alzheimer disease. Raven, New York, pp 75–86Google Scholar
  29. Dyrks T, Dyrks E, Hartmann T, Masters C, Beyreuther K (1992) Amyloidoge-nicity of beta A4 and beta A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J Biol Chem 267 (25): 18210–18217PubMedGoogle Scholar
  30. Dyrks T, Monning U, Beyreuther K, Turner J (1994) Amyloid precursor pro-tein secretion and beta A4 amyloid generation are not mutually exclusive. FEBS Lett 349: 210–214PubMedCrossRefGoogle Scholar
  31. Farber SA, Nitsch RM, Schulz JG, Wurtman R. (1995) Regulated secretion of beta-amyloid precursor protein in rat brain. J Neurosci 15 (11): 7442–7451PubMedGoogle Scholar
  32. Fisher S, Gearhart JD, Oster Granite ML (1991) Expression of the amyloid precursor protein gene in mouse oocytes and embryos. Proc Natl Acad Sci USA 88: 1779–1782PubMedCrossRefGoogle Scholar
  33. Fraser PE, Nguyen JT, Chin DT, Kirschner DA (1992) Effects of sulfate ions on Alzheimer beta/A4 peptide assemblies: implications for amyloid fibril-proteoglycan interactions. J Neurochem 59: 1531–1540PubMedCrossRefGoogle Scholar
  34. Frautschy SA, Cole GM, Baird A (1992) Phagocytosis and deposition of vas-cular beta-amyloid in rat brains injected with Alzheimer beta-amyloid. Am J Pathol 140: 1389–1399PubMedGoogle Scholar
  35. Frisoni GB, Bianchetti A, Govoni S, Trabucchi M, Calabresi L (1994) Associ- ation of apolipoprotein E E4 with vascular dementia. JAMA 271: 1317Google Scholar
  36. Gallo G, Wisniewski T, Choi Miura NH, Ghiso J, Frangione B (1994) Poten- tial role of apolipoprotein-E in fibrillogenesis, Am J Pathol 145: 526–530PubMedGoogle Scholar
  37. Ghiselli G, Schaefer EJ, Zech LA, Gregg RE (1982) Increased prevalence of apoli-poprotein E4 in type V hyperlipoproteinemia. J Clin Invest 70: 474–477PubMedCrossRefGoogle Scholar
  38. Glenner GG, Wong CW (1984) Alzheimer’s disease: initial report of the pufi-cation and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120: 885–890PubMedCrossRefGoogle Scholar
  39. Goedert M (1987) Neuronal localization of amyloid beta protein precursor mRNA in normal human brain and in Alzheimer’s disease. EM130 J 6: 3627–3632Google Scholar
  40. Golde TE, Estus S, Usiak M, Younkin LH, Younkin SG (1990) Expression of beta amyloid protein precursor mRNAs: recognition of a novel alternatively spliced form and quantitation in Alzheimer’s disease using PCR. Neuron 4: 253–267PubMedCrossRefGoogle Scholar
  41. Gray CW (1993) Regulation of beta-amyloid precursor protein isoform mRNAs by transforming growth factor-beta 1 and interleukin-1 beta in astrocytes. Brain Res Mol Brain Res 19: 251–256PubMedCrossRefGoogle Scholar
  42. Greenberg SM, Rebeck GW, Vonsattel JPG, Gomez-Isla T, Hyman BT (1995) Apolipoprotein E4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol 38 (2): 254–259PubMedCrossRefGoogle Scholar
  43. Grubb A, Lofberg H (1985) Human gamma-trace. Structure, function and clinical use of concentration measurements. Scand J Clin Lab Invest Suppl 177: 7–13Google Scholar
  44. Gupta-Bansal R, Frederickson RA, Brunden K (1995) Proteoglycan mediated inhibition of A-beta proteolysis: a potential cause of senile plaque accumulation. J Biol Chem 270 (31): 18666–18671PubMedCrossRefGoogle Scholar
  45. Haan J, Roos RA, Algra PR, Lanser JB, Bots GT, Vegter Van der Vlis M (1990) Hereditary cerebral haemorrhage with amyloidosis — Dutch type. Magnetic resonance imaging findings in 7 cases. Brain 113: 1251–1267Google Scholar
  46. Haan J, Hardy JA, Roos RA (1991) Hereditary cerebral hemorrhage with amyloidosis — Dutch type: its importance for Alzheimer research. Trends Neurosci 14: 231–234PubMedCrossRefGoogle Scholar
  47. Haan J, Bakker E, Jennekens Schinkel A, Roos RA (1992) Progressive dementia, without cerebral hemorrhage, in a patient with hereditary cerebral amyloid angiopathy. Clin Neurol Neurosurg 94: 317–318PubMedCrossRefGoogle Scholar
  48. Haan J, Maat Schieman ML, van Duinen SG, Jensson O, Thorsteinsson L (1994) Co-localization of beta/A4 and cystatin C in cortical blood vessels in Dutch, but not in Icelandic hereditary cerebral hemorrhage with amyloidosis. Acta Neurol Scand 89: 367–371PubMedCrossRefGoogle Scholar
  49. Haass C, Schlossmacher MG, Hung AY, Vigo Pelfrey C, Mellon A, Lieber-burg I, Koo EH, Schenk D, Teplow DB, Selkoe DJ (1992) Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359: 322–325PubMedCrossRefGoogle Scholar
  50. Hachinski VC, Potter P, Merskey H (1987) Leuko-araiosis. Arch Neurol 44: 21–23CrossRefGoogle Scholar
  51. Hall ED, Oostveen JA, Dunn E, Carter DB (1995) Role of amyloid protein precursor and apolipoprotein E in stroke. In: Moskowitz MA, Caplan LR (eds) Cerebrovascular diseases. Nineteenth Princeton Stroke Conference. Butterworth-Heinemann, Boston, pp 251–262Google Scholar
  52. Han SH, Einstein G, Weisgraber KH, Strittmatter WJ, Saunders AM, Roses AD, Schmechel DE (1994) Apolipoprotein E is localized to the cytoplasm of human cortical neurons: a light and electron microscopic study. J Neuropathol Exp Neurol 53: 535–544Google Scholar
  53. Heurteaux C, Bertaina V, Widmann C, Lazdunski M (1993) K+ channel openers prevent global ischemia-induced expression of c-fos,c-jun, heat shock protein, amyloid beta-protein precursor genes and neuronal death in rat hippocampus. Proc Natl Acad Sci USA 90: 9431–9435PubMedCrossRefGoogle Scholar
  54. Hsu CY, An G, Liu JS, Xue JJ, He YY, Lin TN (1993) Expression of immedi-ate early gene and growth factor mRNAs in a focal cerebral ischemia model in the rat. Stroke 24: 178CrossRefGoogle Scholar
  55. Hung AY, Haass C, Nitsch RM, Qiu WQ, Citron M, Wurtman RJ, Growdon JH (1993) Activation of protein kinase C inhibits cellular production of the amyloid beta-protein. J Biol Chem 268: 22959–22962PubMedGoogle Scholar
  56. Hyman BT, Wenniger JJ, Tanzi RE (1993) Nonisotopic in situ hybridization of amyloid beta protein precursor in Alzheimer’s disease: expression in neurofibrillary tangle bearing neurons and in the microenvironment sur-rounding senile plaques. Brain Res Mol Brain Res 18: 253–258PubMedCrossRefGoogle Scholar
  57. Ishihara T, Nagasawa T, Yokota T, Gondo T, Takahashi M, Uchino F (1989) Amyloid protein of vessels in leptomeninges, cortices, choroid plexuses, and pituitary glands from patients with systemic amyloidosis. Hum Pathol 20: 891–895PubMedCrossRefGoogle Scholar
  58. Iwatsubo T, Mann DM, Odaka A, Suzuki N, Ihara Y (1995) Amyloid beta pro-tein (A beta) deposition: A beta 42(43) precedes A beta 40 in Down syn-drome. Ann Neurol 37: 294–299PubMedCrossRefGoogle Scholar
  59. Janota I, Mirsen TR, Hachinski VC, Lee DH, Merskey H (1989) Neuropatho-logic correlates of leuko-araiosis. Arch Neurol 46: 1124–1128PubMedCrossRefGoogle Scholar
  60. Jarrett JT, Lansbury PT (1993) Seeding “one-dimensional crystallization” of amyloid: a pathogenic mechanism in Alzheimer’s disease and scrapie? Cell 73: 1055–1058PubMedCrossRefGoogle Scholar
  61. Jendroska K, Poewe W, Daniel SE, Pluess J (1996) Ischemic stress induces deposition of amyloid beta immunoreactivity in human brain. Acta Neuro-pathol (in press)Google Scholar
  62. Jenkins R, Hunt SP (1991) Long-term increase in the levels of c-jun mRNA and jun protein-like immunoreactivity in motor and sensory neurons fol-lowing axon damage. Neurosci Lett 129: 107–110PubMedCrossRefGoogle Scholar
  63. Joachim CL, Morris JH, Selkoe DJ (1988) Clinically diagnosed Alzheimer’s disease: autopsy results in 150 cases. Ann Neurol 24: 50–56PubMedCrossRefGoogle Scholar
  64. Johnson SA, McNeill T, Cordell B, Finch CE (1990) Relation of neuronal APP-751/APP-695 mRNA ratio and neuritic plaque density in Alzheimer’s disease. Science 248: 854–857PubMedCrossRefGoogle Scholar
  65. Kalaria RN, Harik SI (1989) Abnormalities of the glucose transporter at the blood-brain barrier and in brain in Alzheimer’s disease. Prog Clin Biol Res 317: 415–421PubMedGoogle Scholar
  66. Kalaria RN, Bhatti SU, Lust WD, Perry G (1993) The amyloid precursor pro-tein in ischemic brain injury and chronic hypoperfusion. Ann NY Acad Sci 695: 190–193PubMedCrossRefGoogle Scholar
  67. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Beyreuther K, Miller Hill B (1987) The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell-surface receptor. Nature 325: 733–736PubMedCrossRefGoogle Scholar
  68. Kawai M, Kalaria RN, Hank SI, Perry G (1990) The relationship of amyloid plaques to cerebral capillaries in Alzheimer’s disease. Am J Pathol 137 (6): 1435–1446PubMedGoogle Scholar
  69. Kawai M, Cras P, Perry G (1992) Serial reconstruction of beta-protein amyloid plaques: relationship to microvessels and size distribution. Brain Res 592: 278–282PubMedCrossRefGoogle Scholar
  70. Kingston IB, Castro MJM, Anderson S (1995) In vitro stimulation of tissue-type plasminogen activator by Alzheimer amyloid beta-peptide analogues. Nature Med 1: 138–142PubMedCrossRefGoogle Scholar
  71. Knauer MF, Soreghan B, Burdick D, Kosmoski J, Glabe CG (1992) Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein. Proc Natl Acad Sci USA 89: 7437–7441PubMedCrossRefGoogle Scholar
  72. König G, Salbaum JM, Wiestler O, Lang W, Schmitt HP, Masters CL (1991) Alternative splicing of the beta A4 amyloid gene of Alzheimer’s disease in cortex of control and Alzheimer’s disease patients. Brain Res Mol Brain Res 9: 259–262PubMedCrossRefGoogle Scholar
  73. Koudinov A, Matsubara E, Frangione B, Ghiso J (1994) The soluble form of Alzheimer’s amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma. Biochem Biophys Res Commun 205: 1164–1171PubMedCrossRefGoogle Scholar
  74. Kounnas MZ, Moir RD, Rebeck GW, Bush AI, Argraves WS, Tanzi RE, Hyman BT (1995) LDL receptor–related protein, a multifunctional ApoE receptor, binds secreted beta–amyloid precursor protein and mediates its degradation. Cell 82:331–34–0Google Scholar
  75. Kowalska MA, Badellino K (1994) Beta-amyloid protein induces platelet aggregation and supports platelet adhesion. Biochem Biophys Res Commun 205: 1829–1835PubMedCrossRefGoogle Scholar
  76. LaDu MJ, Pederson TM, FrailDE, Reardon CA, Getz GS, Falduto MT (1995) Purification of apolipoprotein E attentuates isoform-specific binding to beta-amyloid. J Biol Chem 270 (16): 9039–9042Google Scholar
  77. Lassmann H, Bancher C, Breitschopf H, Wegiel J, Bobinski M, Jellinger K (1995) Cell death in Alzheimer’s disease evaluated by DNA fragmentation in situ. Acta Neuropathol (Berl) 89: 35–41CrossRefGoogle Scholar
  78. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, Jondro PD, Schmidt SD, Wang K, Crowley AC, Fu Y, Guenette SY, Galas D, Nemens E, Wijsman EM, Bird TD, Schellenberg GD and Tanzi RE (1995) Candidate gene for the chromosome 1 familial Alzheimer’ s disease locus. Science 269: 973–977PubMedCrossRefGoogle Scholar
  79. Leys D, Pruvo JP, Parent M, Vermersch P, Soetaert G, Steinling M, Defossez A, Rapoport A, Clarisse J, Petit H (1991) Could Wallerian degeneration contribute to “leuko-araiosis” in subjects free of any vascular disorder? J Neurol Neurosurg Psychiatry 54: 46–50PubMedCrossRefGoogle Scholar
  80. Lippa CF, Hamos JE, Smith TW, Pulaski Salo D, Drachman DA (1993) Vas-cular amyloid deposition in Alzheimer’s disease. Neither necessary nor suf-ficient for the local formation of plaques or tangles. Arch Neurol 50: 1088–1092Google Scholar
  81. Luyendijk W, Bots GT, Vegter Van der Vlis M, Went LN, Frangione B (1988) Hereditary cerebral haemorrhage caused by cortical amyloid angiopathy. J Neurol Sci 85: 267–280Google Scholar
  82. Ma J, Yee A, Brewer HB, Jr„ Das S, Potter H (1994) Amyloid-associated pro-teins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature 372: 92–94Google Scholar
  83. Mahley RW (1988) Apolipoprotein E: cholesterol transport protein with ex-panding role in cell biology. Science 240: 622–630PubMedCrossRefGoogle Scholar
  84. Majack RA, Castle CK, Goodrnan LV,Weisgraber KH, Mahley RW, Shooter EM, Gebicke Haerter PJ (1988) Expression of apolipoprotein E by cultured vascular smooth muscle cells is controlled by growth state. J Cell Biol 107 (3): 1207–1213Google Scholar
  85. Mann DM, Purkiss MS, Bonshek RE, Jones D, Brown AM, Stoddart RW (1992) Lectin histochernistry of cerebral microvessels in ageing, Alz-heimer’s disease and Down’s syndrome. Neurobiol Aging 13: 137–143Google Scholar
  86. Mattson MP, Cheng B, Culwell AR, Esch FS, Lieberburg 1, Rydel RE (1993) Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein. Neuron 10: 243–254PubMedCrossRefGoogle Scholar
  87. Matsubara E, Frangione B, Ghiso J (1995) Characterization of apolipoprotein J-Alzheimer’s A beta interaction. J Biol Chem 270 (13): 7563–7567PubMedCrossRefGoogle Scholar
  88. May PC, Finch CE (1992) Sulfated glycoprotein 2: new relationships of this multi-functinal protein to neurodegeneration. Trends Neurosci 15 (10): 391–396PubMedCrossRefGoogle Scholar
  89. Mayeux R, Ottman R, Maestre G, Ngai C, Tang M, Ginsberg H, Chun M, Tycko B, Shelanski M (1995) Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer’s disease. Neuro-logy 45: 555–557Google Scholar
  90. Meda L, Cassatella MA, Szendrei GI, Otvos L, Jr., Baron P, Villalba M, Rossi F (1995) Activation of microglial cells by beta-amyloid protein and interfe-ron-gamma. Nature 374: 647–650PubMedCrossRefGoogle Scholar
  91. Miyakawa T, Katsuragi S, Yamashita K, Ohuchi K (1992) Morphological study of amyloid fibrils and preamyloid deposits in the brain with Alz-heimer’s disease. Acta Neuropathol (Berl) 83: 340–346CrossRefGoogle Scholar
  92. Mooradian AD (1988) Effect of aging on the blood-brain barrier. Neurobiol Aging 9: 31–39PubMedCrossRefGoogle Scholar
  93. Miiller U, Cristina N, Li ZW, Wolfer DP, Lipp HP, Rulicke T, Brandner S, Weissmann C (1994) Behavioral and anatomical deficits in mice homozy-gous for a modified beta-amyloid precursor protein gene. Cell 79: 755–765CrossRefGoogle Scholar
  94. Müller WE, Koch S, Eckert A, Hartmann H, Scheuer K (1995) Beta-amyloid peptide decreases membrane fluidity. Brain Res 674: 133–136PubMedCrossRefGoogle Scholar
  95. Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer’s disease and kuru plaque amyloid in CreutzfeldtJakob disease. Brain Res 541: 163–166Google Scholar
  96. Näslund J, Thyberg J, Tjernberg LO, Wemstedt C, Karlstrom AR, Gandy SE, Lannfelt L, Terenius L, Nordstedt C (1995) Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer’s disease brain. Neuron 15: 219–228Google Scholar
  97. Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE (1994) Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264: 850–852PubMedCrossRefGoogle Scholar
  98. Neve RL, Rogers J, Higgins GA (1990) The Alzheimer amyloid precursor-related transcript lacking the beta/A4sequence is specifically increased in Alzheimer’s disease brain. Neuron 5: 329–338PubMedCrossRefGoogle Scholar
  99. Noguchi S, Murakami K, Yamada N (1993) Apolipoprotein E genotype and Alzheimer’s disease. Lancet 342: 737Google Scholar
  100. Nordstedt C, Naslund J, Tjernberg LO, Karlstrom AR, Thyberg J, Terenius L (1994) The Alzheimer A beta peptide develops protease resistance in association with its polymerization into fibrils. J Biol Chem 269: 30773–30776PubMedGoogle Scholar
  101. Nukina N, Kanazawa I, Mannen T, Uchida Y (1992) Accumulation of amyloid precursor protein and beta-protein immunoreactivities in axons injured by cerebral infarct. Gerontology 38 [Suppl 1]: 10–14PubMedCrossRefGoogle Scholar
  102. Ohgami T, Kitamoto T, Tateishi J (1992) Alzheimer’s amyloid precursor protein accumulates within axonal swellings in human brain lesions. Neurosci Lett 136: 75–78PubMedCrossRefGoogle Scholar
  103. Osuntokun BO, Sahota A, Ogunniyi AO, Gureje O, Baiyewu O, Adeyinka A, Oluwole SO, Komolafe O, Hall KS, Unverzagt FW, Hui SL, Yang M, Hendrie HC (1995) Lack of an association between apolipoprotein e epsilon4 and Alzheimer’s disease in elderly Nigerians. Ann Neurol 38: 463–465PubMedCrossRefGoogle Scholar
  104. Oyama F, Shimada H, Oyama R, Titani K, Ihara Y (1991) Differential expression of beta amyloid protein precursor (APP) and tau mRNA in the aged human brain: individual variability and correlation. J Neuropathol Exp Neurol 50: 560–578PubMedCrossRefGoogle Scholar
  105. Oyama F, Cairns NJ, Shimada H, Oyama R, Titani K, Ihara Y (1994) Down’s syndrome: up-regulation of beta-amyloid protein precursor and tau mRNAs and their defective coordination. J Neurochem 62: 1062–1066PubMedCrossRefGoogle Scholar
  106. Palacios G, Mengod G, Tortosa A, Ferrer I, Palacios JM (1995) Increased beta-amyloid precursor protein expression in astrocytes in the gerbil hippo-campus following ischaemia: association with proliferation of astrocytes. Eur J Neurosci 7: 501–510PubMedCrossRefGoogle Scholar
  107. Palsdottir A, Abrahamson M, Thorsteinsson L, Arnason A, Olafsson I, Jensson O (1988) Mutation in cystatin C gene causes hereditary brain haemorrhage. Lancet 2: 603–604PubMedCrossRefGoogle Scholar
  108. Pardridge WM (1988) Does the brain’s gatekeeper falter in aging? Neurobiol Aging 9: 44–46PubMedCrossRefGoogle Scholar
  109. Pike CJ, Cummings BJ, Monzavi R, Cotman CW (1994) Beta-amyloid-in-duced changes in cultured astrocytes parallel reactive astrocytosis associ-ated with senile plaques in Alzheimer’s disease. Neuroscience 63: 517–531PubMedCrossRefGoogle Scholar
  110. Plump AS, Smith JD, Hayek T, Aalto Setala K, Walsh A, Verstuyft JG, Bres-low JL (1992) Severe hypercholesterolemia and atherosclerosis in apolipo-protein E-deficient mice created by homologous recombination in ES cells. Cell 71: 343–353PubMedCrossRefGoogle Scholar
  111. Pluta R, Kida E, Lossinsky AS, Golabek AA, Mossakowski MJ, Wisniewski HM (1994) Complete cerebral ischemia with short-term survival in rats in-duced by cardiac arrest. I. Extracellular accumulation of Alzheimer’s beta-amyloid protein precursor in the brain. Brain Res 649: 323–328Google Scholar
  112. Popko B, Goodrum JF, Bouldin TW, Zhang SH, Maeda N (1993) Nerve re-generation occurs in the absence of apolipoprotein E in mice. J Neurochem 60: 31: 1155–1158CrossRefGoogle Scholar
  113. Querfurth HW, Selkoe DJ (1994) Calcium ionophore increases amyloid beta peptide production by cultured cells. Biochemistry 33: 4550–4561PubMedCrossRefGoogle Scholar
  114. Ragno M, Tournier-Lasserve E, Fiori M, Mama A (1995) An Italian kindred with cerebral autosomal dominat arteriopathy with subcortical infarcts and leukoencephalopathy ( CADASIL ). Ann Neurol 38: 231–236Google Scholar
  115. Rebeck GW, Reiter JS, Strickland DK, Hyman BT (1993) Apolipoprotein E in sporadic Alzheimer’s disease: allelic variation and receptor interactions. Neuron 11: 575–580Google Scholar
  116. Rebeck GW, Harr SD, Strickland DK, Hyman BT (1995) Multiple, diverse se-nile plaque-associated proteins are ligands of anapolipoprotein E receptor, the alpha 2-macroglobulinreceptor/low-density-lipoprotein receptor-related protein. Ann Neurol 37: 211–217Google Scholar
  117. Rezek DL, Morris JC, Fulling KH, Gado MH (1987) Periventricular white matter lucencies in senile dementia of the Alzheimer type and in normal aging. Neurology 37: 1365–1368PubMedCrossRefGoogle Scholar
  118. Roberts GW, Lofthouse R, Allsop D, Landon M, Kidd M, Prusiner SB, Crow TJ (1988) CNS amyloid proteins in neurodegenerative diseases. Neurology 38: 1534–1540PubMedCrossRefGoogle Scholar
  119. Roberts GW, Gentleman SM, Lynch A, Graham DI (1991) Beta A4 amyloid protein deposition in brain after head trauma. Lancet 338: 1422–1423PubMedCrossRefGoogle Scholar
  120. Robison PM, Clemens JA, Smalstig EB, Stephenson D, May PC (1993) De-crease in amyloid precursor protein precedes hippocampal degeneration in rat brain following transient global ischemia. Brain Res 608: 334–337PubMedCrossRefGoogle Scholar
  121. Roher AE, Lowenson JD, Clarke S, Woods AS, Cotter RJ, Gowing E, Ball MJ (1993) Beta-amyloid-(1–42) is a major component of cerebrovascular amy-loid deposits: implications for the pathology of Alzheimer disease. Proc Natl Acad Sci USA 90: 10836–10840PubMedCrossRefGoogle Scholar
  122. Rosenblum WI, Haider A (1988) Negative correlations between parenchymal amyloid and vascular amyloid in hippocampus. Am J Pathol 130: 532–536PubMedGoogle Scholar
  123. Roses AD, Saunders AM, Alberts MA, Strittmatter WJ, Schmechel D, Gorder E (1995) Apolipoprotein E E4 allele and risk of dementia. JAMA 273: 374–375Google Scholar
  124. Rozemuller JM, Eikelenboom P, Kamphorst W, Stam FC (1988) Lack of evi-dence for dysfunction of the blood-brain barrier in Alzheimer’sdisease: an immunohistochemical study. Neurobiol Aging 9: 383–391PubMedCrossRefGoogle Scholar
  125. Salbaum JM, Weidemann A, Lemaire HG, Masters CL, Beyreuther K (1988) The promoter of Alzheimer’s disease amyloid A4 precursor gene. EMBO J 7: 2807–2813PubMedGoogle Scholar
  126. Saunders AM, Strittmatter WJ, Schmechel D, George Hyslop PH, Joo SH, Rosi BL, Gusella JF, Crapper MacLachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses AD (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer’s disease. Neurology 43: 1467–1472Google Scholar
  127. Scheibel AB, Duong TH, Jacobs R (1989) Alzheimer’s disease as a capillary dementia. Ann Med 21: 103–107PubMedCrossRefGoogle Scholar
  128. Scheltens P, Barkhof F, Leys D, Wolters EC, Ravid R, Kamphorst W (1995) Histopathologic correlates of white matter changes on MRI in Alzheimer’s disease and normal aging. Neurology 45: 883–888PubMedCrossRefGoogle Scholar
  129. Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Goldgaber D, Roses AD (1993) Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 90; 9649–9653CrossRefGoogle Scholar
  130. Schneider JA, Gearing M, Robbins RS, de Mirra ASS (1995) Apolipoprotein E genotype in diverse neurodegenerative disorders. Ann Neurol 38: 131–135Google Scholar
  131. Scholz W (1938) Studien zur Pathologic der Hirngefässe II. Die drusige Entar-tung der Hirnarterien und -capillaren. Z Ges Neurol Psychiatr 162: 694–715CrossRefGoogle Scholar
  132. Schubert D, LaCorbiere M, Saitoh T, Cole G (1989) Characterization of an amyloid beta precursor protein that binds heparin and contains tyrosine sul-fate. Proc Natl Acad Sci USA 86: 2066–2069PubMedCrossRefGoogle Scholar
  133. Schwarzman AL, Gregori L, Vitek MP, Lyubski S et al (1994) Transthyretin sequesters amyloid beta protein and prevents amyloid formation Proc Natl Acad Sci USA91:8368–8372Google Scholar
  134. Shigematsu K, McGeer PL (1992) Accumulation of amyloid precursor protein in neurons after intraventricular injection of colchicine. Am J Pathol 140: 787–794PubMedGoogle Scholar
  135. Shirahama T, Skinner M, Cohen AS (1981) Immunocytochemical identification of amyloid in formalin-fixed paraffin sections. Histochemistry 72: 161–171PubMedCrossRefGoogle Scholar
  136. Snow AD, Sekiguchi R, Nochlin D, Fraser P, Kimata K, Mizutani A, Arai M, Morgan DG (1994) An important role of heparan sulfate proteoglycan ( Perlecan) in a mode system for the deposition and persistence of fibrillar A beta-amyloid in ratbrain. Neuron 12: 219–234Google Scholar
  137. Sola C, Garcia Ladona FJ, Mengod G, Probst A, Frey P, Palacios JM (1993) Increased levels of the Kunitz protease inhibitor-containing beta APP mRNAs in rat brain following neurotoxic damage. Brain Res Mol Brain Res 17: 41–52PubMedCrossRefGoogle Scholar
  138. St. Clair D, Non-man J, Perry R, Yates C, Wilcock G, Brookes A (1994) Apolipoprotein E epsilon 4 allele frequency in patients with Lewy body dementia, Alzheimer’s disease and age-matched controls. Neurosci Lett 176: 45–46Google Scholar
  139. Stephenson DT, Rash K, Clemens JA (1992) Amyloid precursor protein accumulates in regions of neurodegeneration following focal cerebral ischemia in the rat. Brain Res 593: 128–135PubMedCrossRefGoogle Scholar
  140. Stewart PA, Hayakawa K, Akers MA, Vinters HV (1992) A morphometric study of the blood-brain barrier in Alzheimer’s disease. Lab Invest 67: 734–742PubMedGoogle Scholar
  141. Stoll G, Müller HW (1986) Macrophages in the peripheral nervous system and astroglia in the central nervous system of rat commonly express apolipoprotein E during development but differ in their response to injury. Neurosci Lett 72: 233–238Google Scholar
  142. Stoll G, Müller HW, Trapp BD, Griffin JW (1989) Oligodendrocytes but not astrocytes express apolipoprotein E after injury of rat optic nerve. Glia 2: 170–176Google Scholar
  143. Suzuki N, Cheung TT, Cai XD, Odaka A, Otvos L, Jr., Eckman C, Golde TE (1994) An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science 264: 1336–1340PubMedCrossRefGoogle Scholar
  144. Tabaton M, Caponnetto C, Mancardi G, Loeb C (1991) Amyloid beta protein deposition in brains from elderly subjects with leukoaraiosis. J Neurol Sci 106: 123–127PubMedCrossRefGoogle Scholar
  145. Tanaka S, Nakamura S, Ueda K, Kameyama M, Shiojiri S, Takahashi Y, Ito H (1988) Three types of amyloid protein precursor mRNA in human brain: their differential expression in Alzheimer’s disease. Biochem Biophys Res Commun 157: 472–479PubMedCrossRefGoogle Scholar
  146. Tanaka S, Shiojiri S, Takahashi Y, Kitaguchi N, Ito H, Kameyama M, Nakamura S, Ueda K (1989) Tissue-specific expression of three types of beta-protein precursor mRNA:enhancement of protease inhibitor-harboring types in Alzheimer’s disease brain. Biochem Biophys Res Commun 165: 1406–1414PubMedCrossRefGoogle Scholar
  147. Tanzi RE, Gusella JF, Watkins PC, Bruns GA, St George Hyslop P, Patterson D, Pagan S, Kurnit DM, Neve RL (1987) Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 235: 880–884PubMedCrossRefGoogle Scholar
  148. Tennent GA, Lovat LB, Pepys MB (1995) Serum amyloid P component pre-vents proteolysis of the amyloid fibrils ofAlzheimer disease and systemic amyloidosis. Proc Natl Acad Sci USA 92: 4299–4303PubMedCrossRefGoogle Scholar
  149. Terry RD, Hansen LA, DeTeresa R, Davies P, Tobias H, Katzman R (1987) Senile dementia of the Alzheimer type without neocortical neurofibrillary tangles. J Neuropathol Exp Neurol 46 (3): 262–268PubMedCrossRefGoogle Scholar
  150. Timmers WF, Tagliavini F, Haan J, Frangione B (1990) Parenchymal preamy-loid and amyloid deposits in the brains of patients with hereditary cerebral hemorrhage with amyloidosis — Dutch type. Neurosci Lett 118: 223–226PubMedCrossRefGoogle Scholar
  151. Tomimoto H, Wakita H, Akiguchi I, Nakamura S, Kimura J (1994) Temporal profiles of accumulation of amyloid beta/A4 protein precursor inthe gerbil after graded ischemic stress. J Cereb Blood Flow Metab 14: 565–573PubMedCrossRefGoogle Scholar
  152. Tomimoto H, Akiguchi I, Wakita H, Nakamura S, Kimura J (1995) Ultrastruc-tural localization of amyloid protein precursor in the normal and posti-schemic gerbil brain. Brain Res 672: 187–195PubMedCrossRefGoogle Scholar
  153. van Bockxmeer FM, Mamotte CD (1992) Apolipoprotein epsilon 4 homozy- gosity in young men with coronary heart disease. Lancet 340: 879–880PubMedCrossRefGoogle Scholar
  154. van Duinen SG, Castano EM, PreIli F, Bots GT, Luyendijk W, Frangione B (1987) Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origins related to Alzheimer disease. Proc Natl Acad Sci USA 84: 5991–5994PubMedCrossRefGoogle Scholar
  155. Vinters HV (1987) Cerebral amyloid angiopathy. A critical review. Stroke 18: 311–324PubMedCrossRefGoogle Scholar
  156. Vinters HV (1991) Relationship of amyloid to Alzheimer’s disease. West J Med 154(1)94–95Google Scholar
  157. Vinters HV, Secor DL, Pardridge WM, Gray F (1990) Immunohistochemical study of cerebral amyloid angiopathy. III. Widespread Alzheimer A4 pep-tide in cerebral microvessel walls colocalizes with gamma tracein patients with leukoencephalopathy. Ann Neurol 28: 34–42PubMedCrossRefGoogle Scholar
  158. Wakita H, Tomimoto H, Akiguchi I, Ohnishi K, Nakamura S, Kimura J (1992) Regional accumulation of amyloid beta/A4 protein precursor in the gerbil brain following transient cerebral ischemia. Neurosci Lett 146: 135–138PubMedCrossRefGoogle Scholar
  159. Waldemar G, Christiansen P, Larsson HB, Hogh P, Laursen H, Lassen NA (1994) White matter magnetic resonance hyperintensities in dementia of the Alzheimer type: morphological and regional cerebral blood flow correlates. J Neurol Neurosurg Psychiatry 57: 1458–1465PubMedCrossRefGoogle Scholar
  160. Wallace W, Ahlers ST, Gotlib J, Bragin V, Sugar J, Gluck R, Shea PA, Haroutunian V (1993) Amyloid precursor protein in the cerebral cortex is rapidly and persistently induced by loss of subcortical innervation. Proc Natl Acad Sci USA 90: 8712–8716PubMedCrossRefGoogle Scholar
  161. Weisgraber KH, Roses AD, Strittmatter WJ (1994) The role of apolipoprotein E in the nervous system. Curr Opin Lipidol 5: 110–116CrossRefGoogle Scholar
  162. Wisniewski T, Ghiso J, Frangione B (1991) Peptides homologous to the amyloid protein of Alzheimer’s disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation. Biochem Biophys Res Commun 180: 1528PubMedCrossRefGoogle Scholar
  163. Wisniewski T, Castano EM, Golabek A, Vogel T, Frangione B (1994) Acceleration of Alzheimer’s fibril formation by apolipoprotein E in vitro. Am J Pathol 145: 1030–1035Google Scholar
  164. Yamada T, Kondo A, Takamatsu J, Tateishi J, Goto I (1995) Apolipoprotein E mRNA in the brains of patients with Alzeimer’s disease. J Neurol Sci 129 (1): 56–61Google Scholar
  165. Yamaguchi H, Ishiguro K, Sugihara S, Nakazato Y, Kawarabayashi T, Sun X (1994) Presence of apolipoprotein E on extracellular neurofibrillary tangles and on meningeal blood vessels precedes the Alzheimer beta-amyloid deposition. Acta Neuropathol (Berl) 88: 413–419Google Scholar
  166. Yankner BA, Duffy LK, Kirschner DA (1990) Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 250: 279–282PubMedCrossRefGoogle Scholar
  167. Zhang SH, Reddick RL, Piedrahita JA, Maeda N (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258: 468–471Google Scholar
  168. Zlokovic BV, Ghiso J, Mackic JB, McComb JG, Weiss MH, Frangione B (1993) Blood-brain barrier transport of circulating Alzheimer’s amyloid beta. Biochem Biophys Res Commun 197: 1034–1040PubMedCrossRefGoogle Scholar
  169. Zlokovic BV, Martel CL, Mackic JB, Matsubara E, Wisniewski T, McComb JG, Ghiso J (1994) Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer’s amyloid beta. Biochem Biophys Res Commun 205: 1431–1437Google Scholar
  170. Zlokovic BV, Martel CL, Matsubara E, Frangione G, Ghiso J (1995) Cellular uptake of apolipoprotein J and Alzheimer’s amyloid beta complexed to apolipoprotein J at the blood-brain barrier and in the choroid plexus Soc Neurosci Abstr 21: 6Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • J. G. Schulz
  • K. M. Einhäupl

There are no affiliations available

Personalised recommendations